Jens Rokkedal

2.2k total citations
31 papers, 1.7k citations indexed

About

Jens Rokkedal is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jens Rokkedal has authored 31 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Cardiology and Cardiovascular Medicine, 7 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jens Rokkedal's work include Cardiovascular Function and Risk Factors (19 papers), Blood Pressure and Hypertension Studies (13 papers) and Cardiovascular Health and Disease Prevention (10 papers). Jens Rokkedal is often cited by papers focused on Cardiovascular Function and Risk Factors (19 papers), Blood Pressure and Hypertension Studies (13 papers) and Cardiovascular Health and Disease Prevention (10 papers). Jens Rokkedal collaborates with scholars based in Denmark, United States and Norway. Jens Rokkedal's co-authors include Kristian Wachtell, Eva Gerdts, Vasilios Papademetriou, Richard B. Devereux, Hans Ibsen, Markku S. Nieminen, Jonathan N. Bella, Kurt Boman, Björn Dahlöf and Michael Hecht Olsen and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Hypertension.

In The Last Decade

Jens Rokkedal

30 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jens Rokkedal Denmark 19 1.6k 311 307 139 128 31 1.7k
Monika Przewłocka‐Kosmala Poland 20 1.1k 0.7× 201 0.6× 308 1.0× 115 0.8× 190 1.5× 51 1.3k
Davide Giorgi Italy 17 676 0.4× 513 1.6× 219 0.7× 94 0.7× 233 1.8× 44 1.2k
Daniel M. Shindler United States 14 1.2k 0.8× 289 0.9× 224 0.7× 191 1.4× 275 2.1× 32 1.6k
Toni Bransford United States 9 1.4k 0.9× 215 0.7× 214 0.7× 202 1.5× 133 1.0× 16 1.5k
Vivienne-Elizabeth Smith United States 10 1.2k 0.8× 136 0.4× 406 1.3× 151 1.1× 82 0.6× 10 1.4k
Ersoy Işık Türkiye 18 767 0.5× 98 0.3× 170 0.6× 178 1.3× 249 1.9× 86 1.1k
Claudia Agabiti Rosei Italy 20 615 0.4× 224 0.7× 196 0.6× 88 0.6× 265 2.1× 73 1.0k
A Bertini Italy 13 476 0.3× 493 1.6× 126 0.4× 80 0.6× 248 1.9× 47 1.1k
Wen‐Chol Voon Taiwan 20 950 0.6× 114 0.4× 265 0.9× 166 1.2× 369 2.9× 147 1.3k
Natalia Pezzali Italy 12 2.0k 1.3× 164 0.5× 550 1.8× 280 2.0× 221 1.7× 17 2.3k

Countries citing papers authored by Jens Rokkedal

Since Specialization
Citations

This map shows the geographic impact of Jens Rokkedal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jens Rokkedal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jens Rokkedal more than expected).

Fields of papers citing papers by Jens Rokkedal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jens Rokkedal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jens Rokkedal. The network helps show where Jens Rokkedal may publish in the future.

Co-authorship network of co-authors of Jens Rokkedal

This figure shows the co-authorship network connecting the top 25 collaborators of Jens Rokkedal. A scholar is included among the top collaborators of Jens Rokkedal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jens Rokkedal. Jens Rokkedal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wachtell, Kristian, Vittorio Palmieri, Eva Gerdts, et al.. (2010). Prognostic Significance of Left Ventricular Diastolic Dysfunction in Patients With Left Ventricular Hypertrophy and Systemic Hypertension (the LIFE Study). The American Journal of Cardiology. 106(7). 999–1005. 35 indexed citations
2.
Olsen, Michael Hecht, Marina K. Christensen, Kristian Wachtell, et al.. (2005). Markers of collagen synthesis is related to blood pressure and vascular hypertrophy: a LIFE substudy. Journal of Human Hypertension. 19(4). 301–307. 27 indexed citations
3.
Wachtell, Kristian, Björn Hornestam, Mika Lehto, et al.. (2005). Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation. Journal of the American College of Cardiology. 45(5). 705–711. 169 indexed citations
4.
Olsen, Michael Hecht, Kristian Wachtell, Christian Tuxen, et al.. (2005). Opposite effects of losartan and atenolol on natriuretic peptides in patients with hypertension and left ventricular hypertrophy: a LIFE substudy. Journal of Hypertension. 23(5). 1083–1090. 32 indexed citations
5.
Olsen, Michael Hecht, Kristian Wachtell, Jonathan N. Bella, et al.. (2005). Losartan but not atenolol reduce carotid artery hypertrophy in essential hypertension. A LIFE substudy. Blood Pressure. 14(3). 177–183. 45 indexed citations
6.
Olsen, Michael Hecht, Kristian Wachtell, Christian Hall, et al.. (2004). 888-1 N-terminal pro brain natriuretic peptide predicts cardiovascular events in patients with hypertension and left ventricular hypertrophy: A LIFE study. Journal of the American College of Cardiology. 43(5). A530–A530. 6 indexed citations
7.
Olsen, Michael Hecht, Kristian Wachtell, Giovanni de Simone, et al.. (2004). Is inappropriate left ventricular mass related to neurohormonal factors and/or arterial changes in hypertension? a LIFE substudy. Journal of Human Hypertension. 18(6). 437–443. 7 indexed citations
8.
Olsen, Michael Hecht, Kristian Wachtell, Christian Meyer, et al.. (2004). Association between vascular dysfunction and reduced myocardial flow reserve in patients with hypertension: a LIFE substudy. Journal of Human Hypertension. 18(6). 445–452. 32 indexed citations
10.
Devereux, Richard B., Kristian Wachtell, Eva Gerdts, et al.. (2003). Prognostic significance of left ventricular hypertrophy during treatment of hypertension: The LIFE study. Journal of the American College of Cardiology. 41(6). 228–228. 2 indexed citations
11.
Olsen, Michael Hecht, Kristian Wachtell, Christian Tuxen, et al.. (2003). N-terminal pro-brain natriuretic peptide predicts cardiovascular events in hypertension: A LIFE substudy. Journal of the American College of Cardiology. 41(6). 276–276.
12.
Wachtell, Kristian, Björn Hornestam, Mika Lehto, et al.. (2003). Cardiovascular morbidity and mortality in hypertensive patients with atrial fibrillation: The LIFE study. Journal of the American College of Cardiology. 41(6). 276–276. 4 indexed citations
13.
Olsen, Michael Hecht, Kristian Wachtell, Jonathan N. Bella, et al.. (2003). The effect of losartan versus atenolol on aortic valve sclerosis: A LIFE study. Journal of the American College of Cardiology. 41(6). 505–506. 3 indexed citations
14.
Olsen, Michael Hecht, Kristian Wachtell, Jonathan N. Bella, et al.. (2002). Left Ventricular Hypertrophy is Associated with Reduced Vasodilatory Capacity in the Brachial Artery in Patients with Longstanding Hypertension. A LIFE Substudy. Blood Pressure. 11(5). 285–292. 6 indexed citations
15.
Wachtell, Kristian, Jonathan N. Bella, Jens Rokkedal, et al.. (2002). Change in Diastolic Left Ventricular Filling After One Year of Antihypertensive Treatment. Circulation. 105(9). 1071–1076. 147 indexed citations
16.
Olsen, Michael Hecht, Kristian Wachtell, Erik Frandsen, et al.. (2002). Is cardiovascular remodeling in patients with essential hypertension related to more than high blood pressure? A LIFE substudy. American Heart Journal. 144(3). 530–537. 48 indexed citations
17.
Wachtell, Kristian, Björn Dahlöf, Jens Rokkedal, et al.. (2002). Change of left ventricular geometric pattern after 1 year of antihypertensive treatment: The Losartan Intervention For Endpoint reduction in hypertension (LIFE) study. American Heart Journal. 144(6). 1057–1064. 59 indexed citations
18.
Wachtell, Kristian, Jens Rokkedal, Jonathan N. Bella, et al.. (2001). Effect of electrocardiographic left ventricular hypertrophy on left ventricular systolic function in systemic hypertension (the LIFE study). The American Journal of Cardiology. 87(1). 54–60. 59 indexed citations
19.
Andersen, Ulrik B., Frank Steensgaard-Hansen, Jens Rokkedal, Hans Ibsen, & H Dige‐Petersen. (2001). Left Ventricular Structure and Diastolic Function in Subjects with Two Hypertensive Parents. Blood Pressure. 10(4). 193–198. 3 indexed citations
20.
Bella, Jonathan N., Kristian Wachtell, Vittorio Palmieri, et al.. (2001). Relation of left ventricular geometry and function to systemic hemodynamics in hypertension: The LIFE Study. Journal of Hypertension. 19(1). 127–134. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026